Summary of Purpose
Transient ischemic attack (TIA) or minor ischemic stroke has a high risk of early recurrent stroke. As the golden standard, aspirin effect modestly on acute ischemic stroke, and slightly increase the risk of intracerebral hemorrhage. Recently, rivaroxaban, a new oral anticoagulant, is proved to be as effective as traditional anticoagulants, while carrying significantly less risk of intracranial hemorrhage. ...Read More →
The following dates are available for this trial. Trial information last updated on 13 August 2013.
|1 Sep 2013||19 Jul 2013||1 Sep 2015||1 Apr 2016||1 Aug 2013||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Xijing Hospital Lead
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
- Xuedong Liu, M.D.
email@example.com +86 029 84775055